Phenominer Database Results (22 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Clinical Measurement Notes Experiment Notes Record ID Study ID
SR/Hsd plasma osmolality controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood molecular composition trait male 91.0 days-119.0 days 6 299.6 umol/g 4.5 11.02 osmometry 0.0 p osmolality mosm/kg 102237 2682
SS/Hsd plasma osmolality controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood molecular composition trait male 91.0 days-119.0 days 6 300.3 umol/g 4.7 11.51 osmometry 0.0 p osmolality mosm/kg 102245 2682
SR/Hsd plasma osmolality controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood molecular composition trait male 91.0 days-119.0 days 6 301.6 umol/g 3.8 9.31 osmometry 0.0 p osmolality mosm/kg 102239 2682
SR/Hsd plasma osmolality controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood molecular composition trait male 91.0 days-119.0 days 6 300.6 umol/g 2.8 6.86 osmometry 0.0 p osmolality mosm/kg 102258 2682
SR/Hsd plasma osmolality controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood molecular composition trait male 91.0 days-119.0 days 6 298.7 umol/g 3.2 7.84 osmometry 0.0 p osmolality mosm/kg 102259 2682
SS/Hsd plasma osmolality controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood molecular composition trait male 91.0 days-119.0 days 6 299.4 umol/g 3.8 9.31 osmometry 0.0 p osmolality mosm/kg 102263 2682
SR/Hsd plasma osmolality controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood molecular composition trait male 91.0 days-119.0 days 6 300.9 umol/g 3.7 9.06 osmometry 0.0 p osmolality mosm/kg 102260 2682
SS/Hsd plasma osmolality controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood molecular composition trait male 91.0 days-119.0 days 6 301.2 umol/g 3.2 7.84 osmometry 0.0 p osmolality mosm/kg 102264 2682
SD-Htr7em1Msu plasma osmolality control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood homeostasis trait male 91.0 days-154.0 days 287.3 umol/g 2.75 osmometry 0.0 calculated plasma osmolality - mmol/kg body weight 111472 3067
SD-Htr7em1Msu plasma osmolality control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood homeostasis trait female 91.0 days-154.0 days 284.0 umol/g 1.98 osmometry 0.0 calculated plasma osmolality - mmol/kg body weight 111473 3067
Crl:SD plasma osmolality control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood homeostasis trait female 91.0 days-154.0 days 284.8 umol/g 1.02 osmometry 0.0 calculated plasma osmolality - mmol/kg body weight 111471 3067
SS/Hsd plasma osmolality controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood molecular composition trait male 91.0 days-119.0 days 6 301.3 umol/g 4.3 10.53 osmometry 0.0 102248 2682
SR/Hsd plasma osmolality controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood molecular composition trait male 91.0 days-119.0 days 6 298.6 umol/g 3.8 9.31 osmometry 0.0 p osmolality mosm/kg 102257 2682
MHS plasma osmolality control condition Capasso G, et al., Am J Physiol Renal Physiol. 2005 Jun;288(6):F1173-82. doi: 10.1152/ajprenal.00228.2004. Epub 2005 Feb 1. blood molecular composition trait not specified 23.0 days-25.0 days 11 293.7 umol/g 1.5 4.97 osmometry 0.0 104163 2926
SS/Hsd plasma osmolality controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood molecular composition trait male 91.0 days-119.0 days 6 301.8 umol/g 3.8 9.31 osmometry 0.0 p osmolality mosm/kg 102246 2682
SS/Hsd plasma osmolality controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) then sham surgical control condition (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood molecular composition trait male 91.0 days-119.0 days 6 301.4 umol/g 4.2 10.29 osmometry 0.0 p osmolality mosm/kg 102261 2682
MNS plasma osmolality control condition Capasso G, et al., Am J Physiol Renal Physiol. 2005 Jun;288(6):F1173-82. doi: 10.1152/ajprenal.00228.2004. Epub 2005 Feb 1. blood molecular composition trait not specified 23.0 days-25.0 days 11 298.3 umol/g 2.3 7.63 osmometry 0.0 104162 2926
SR/Hsd plasma osmolality controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood molecular composition trait male 91.0 days-119.0 days 6 302.4 umol/g 4.2 10.29 osmometry 0.0 p osmolality mosm/kg 102238 2682
SR/Hsd plasma osmolality controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood molecular composition trait male 91.0 days-119.0 days 6 301.3 umol/g 4.4 10.78 osmometry 0.0 102240 2682
SS/Hsd plasma osmolality controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then scrambled control oligodeoxynucleotide (4.17 ug/d) (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood molecular composition trait male 91.0 days-119.0 days 6 301.6 umol/g 3.9 9.55 osmometry 0.0 p osmolality mosm/kg 102247 2682
SS/Hsd plasma osmolality controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days) Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13. blood molecular composition trait male 91.0 days-119.0 days 6 301.8 umol/g 3.6 8.82 osmometry 0.0 p osmolality mosm/kg 102262 2682
Crl:SD plasma osmolality control condition Demireva EY, etal., Physiol Genomics. 2019 Jul 1;51(7):290-301. doi: 10.1152/physiolgenomics.00030.2019. Epub 2019 May 24. blood homeostasis trait male 91.0 days-154.0 days 284.6 umol/g 0.33 osmometry 0.0 calculated plasma osmolality - mmol/kg body weight 111470 3067